Somatoform disorder is a relatively common and severe disorder for which pharmacotherapy has been minimally studied. We report a case of 30-year-old woman with treatment-resistant somatoform disorder that was successfully treated with add-on treatment of gabapentin. Our result showed that gabapentin 1800 mg/day could be tried in case of treatment-resistant somatoform disorder as an add-on strategy. However, controlled trials are needed to investigate the effectiveness of gabapentin in the management of this condition.
Guglielmo, R., Martinotti, G., Janiri, L., Gabapentin as add-on treatment for somatoform disorder: a case report, <<CLINICAL NEUROPHARMACOLOGY>>, 2012; 35 (1): 45-46. [doi:10.1097/WNF.0b013e31823e669b] [http://hdl.handle.net/10807/8736]
Gabapentin as add-on treatment for somatoform disorder: a case report
Guglielmo, Riccardo;Martinotti, Giovanni;Janiri, Luigi
2012
Abstract
Somatoform disorder is a relatively common and severe disorder for which pharmacotherapy has been minimally studied. We report a case of 30-year-old woman with treatment-resistant somatoform disorder that was successfully treated with add-on treatment of gabapentin. Our result showed that gabapentin 1800 mg/day could be tried in case of treatment-resistant somatoform disorder as an add-on strategy. However, controlled trials are needed to investigate the effectiveness of gabapentin in the management of this condition.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
